a public good project by the
Synthesis
Company
of California

© 2026

Linda Fogelstrand | doi.page

0 works0 citations0 h-index

Linda Fogelstrand

Sahlgrenska University Hospital(SE)Region Västra Götaland(SE)University of Gothenburg(SE)

Publications by Year

Research Areas

Acute Myeloid Leukemia Research, Acute Lymphoblastic Leukemia research, Chronic Myeloid Leukemia Treatments, Myeloproliferative Neoplasms: Diagnosis and Treatment, Cancer Genomics and Diagnostics

Most-Cited Works

→ The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms(2022)3,654 cited
→ Oxidation-specific epitopes are dominant targets of innate natural antibodies in mice and humans(2009)460 cited
→ Induction of proinflammatory cytokines by long-chain saturated fatty acids in human macrophages(2008)233 cited
→ The genomic landscape of high hyperdiploid childhood acute lymphoblastic leukemia(2015)192 cited
→ Oxidation‐specific epitopes are important targets of innate immunity(2008)176 cited
→ Phosphoinositide 3-Kinase p110δ Regulates Natural Antibody Production, Marginal Zone and B-1 B Cell Function, and Autoantibody Responses(2009)119 cited

→ Residual disease detected by flow cytometry is an independent predictor of survival in childhood acute myeloid leukaemia; results of the NOPHO‐AML 2004 study(2016)82 cited

→ Monocytic expression of CD14 and CD18, circulating adhesion molecules and inflammatory markers in women with diabetes mellitus and impaired glucose tolerance(2004)64 cited

→ Minimal residual disease quantification by flow cytometry provides reliable risk stratification in T-cell acute lymphoblastic leukemia(2018)56 cited

→ α7 Nicotinic Acetylcholine Receptor Is Expressed in Human Atherosclerosis and Inhibits Disease in Mice—Brief Report(2014)51 cited